Welcome

Synome Ltd is a biotechnology company that utilises innovative approaches to study diseases of the brain. We specialise in translating knowledge of the genetic basis of brain diseases into new therapies. Synome actively partners with the academic and commercial sector for fundamental research on the brain and for the development of new therapeutic approaches. Synome has established a unique and integrated portfolio bridging the gaps between the latest scientific advances and drug discovery.